This inventor holds 2 USPTO granted patents and 9 published patent applications. Top assignees: Johns Hopkins University, The United States of America, as Represented by Th, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,803 
1 out of 1 
1 out of 3,697 
Years Active: 2022-2025
Title: **Inventor Spotlight: Andres Dulcey Garcia**
Introduction
Andres Dulcey Garcia is an innovative inventor based in Gaithersburg, Maryland, recognized for his contributions to the field of virology. With a total of two patents, he has dedicated his efforts to advancing methods for the prevention and treatment of human cytomegalovirus (HCMV). His work has important implications for medical treatments and pharmaceutical compositions.
Latest Patents
One of Garcia's latest patents focuses on the use of low dose emetine for inhibiting human cytomegalovirus (HCMV). This invention outlines methods and compositions that can significantly enhance prevention and treatment options for HCMV. The patent details a pharmaceutical composition which includes emetine or a derivative, a human cytomegalovirus drug, and a pharmaceutically acceptable carrier. Notably, in certain embodiments, the composition may also contain an adjuvant, with the HCMV drug specified as ganciclovir. The innovative aspect lies in the utilization of emetine at a dosage that is approximately 1/10 to 1/100 of the normal dosage for treating amebiasis.
Career Highlights
Throughout his career, Andres Garcia has held positions at notable organizations such as The Johns Hopkins University and the United States of America, as represented by the Department of Health and Human Services. His work in these institutions has allowed him to collaborate on significant research projects that contribute to the scientific community's understanding of virology.
Collaborations
Garcia has had the privilege of working alongside esteemed colleagues, including Ravit Boger and Marc Ferrer. These collaborations have fostered an environment of innovation and shared knowledge, ultimately leading to advancements in the fight against viral infections.
Conclusion
Andres Dulcey Garcia exemplifies the spirit of innovation in the medical field. His two patents demonstrate his commitment to enhancing treatment options for conditions such as human cytomegalovirus. Through his career and collaborations, he continues to make impactful contributions that highlight the importance of research and development in virology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile